SCHEMBL19919054

SCHEMBL19919054

COc1cc(C(=O)NC2CCNCC2)ccc1Nc1ncc(Cl)c(Oc2cccc3c2C(=O)N(C)C3)n1

nearest known ligand 0.87

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ PTK2 Q05397 20/20 0.87

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12135024 0.93 PTK2 (1.00) PTK2
SCHEMBL19919013 0.90 PTK2 (0.87) PTK2
SCHEMBL19918924 0.90 PTK2 (0.89) PTK2
SCHEMBL19918920 0.89 PTK2 (0.87) PTK2
SCHEMBL19918969 0.87 PTK2 (0.86) PTK2
SCHEMBL12137014 0.85 PTK2 (0.85) PTK2
SCHEMBL19919049 0.85 PTK2 (0.90) PTK2
SCHEMBL12135603 0.83 PTK2 (1.00) PTK2
SCHEMBL12135475 0.83 PTK2 (1.00) PTK2
SCHEMBL1356248 0.83 PTK2 (1.00) PTK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2367800-B1 SUBSTITUTED PYRIMIDINES FOR THE TREATMENT OF DISEASES SUCH AS CANCER BOEHRINGER INGELHEIM INT (DE) 2018-02-28 — — EP disclosed
Send feedback